The dose-dependent H2O2 stress response promotes increased survival for Schizosaccharomyces pombe cells expressing HIV-1 Vpr

Folia Microbiologica

Volumn 51, Issue 5, 2006, Pages 406-412

  Antal, J ^a   Pesti, M ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; SCHIZOSACCHAROMYCES POMBE;

HYDROGEN PEROXIDE; VPR PROTEIN;

ARTICLE; CELL CYCLE; CELL PROLIFERATION; CELL SURVIVAL; DOSE RESPONSE; DRUG EFFECT; GENETICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; METABOLISM; OXIDATIVE STRESS; PHYSIOLOGY; SCHIZOSACCHAROMYCES; VIROLOGY;

CELL CYCLE; CELL PROLIFERATION; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE PRODUCTS, VPR; HIV-1; HUMANS; HYDROGEN PEROXIDE; OXIDATIVE STRESS; SCHIZOSACCHAROMYCES;

EID: 33751349533     PISSN: 00155632     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02931584     Document Type: Article

References (41)

1. ALTFELD M., ADDO M.M., ELDRIDGE R.L., YU X.G., THOMAS S., KHATRI A., STRICK D., PHILLIPS M.N., COHEN G.B., ISLAM S.A., KALAMS S.A., BRANDER C., GOULDER P.J.R., ROSENBERG E.S., WALKER B.D. and the HIV Study Collaboration: Vpr is preferentially targeted by CTL during HIV-1 infection. J.Immunol. 167, 2743-2752 (2001).
2. ARIEN K.K., TROYER R.M., GALI Y., COLEBUNDERS R.L., ARTS E.J.P., VANHAM G.: Replicative fitness of historical and recent HIV-1 isolates suggest HIV-1 attenuation over time. AIDS 19, 1555-1564 (2005)
3. BASANEZ G., ZIMMERBERG J.: HIV and apoptosis: death and the mitochondrion. J.Exp.Med. 193, 11-14 (2001).
4. BENKO Z., LIANG D., AGBOTTAH E., HOU J., CHIU K., YU M., INNIS S., REED P., KABAT W., ELDER R.T., DI MARZIO P., TARICANI L., RATNER L., YOUNG P.G., BUKRINSKY M., ZHAO Y.: Anti-Vpr activity of a yeast chaperone protein. J.Virol. 78, 11016-11029 (2004).
5. BUCK V., QUINN J., PINO T.S., MARTIN H., SALDANHA J., MAKINO K., MORGAN B.A., MILLAR J.B.A.: Peroxide sensors for the fission yeast stress-activated mitogen-activated protein kinase pathway. Mol.Biol.Cell 12, 407-419 (2001).
6. 2 arrest, nuclear localization, and cell death in fission yeast. J. Virol. 73, 3236-3245 (1999).
7. CHEN D., TOONE W.M., MATA J., LYNE R., BURNS G., KIVINEN K., BRAZMA A., JONES N., BAHLER J.: Global transcriptional responses of fission yeast to environmental stress. Mol.Biol.Cell 14, 214-229 (2003).
8. CHLÁDKOVÁ K., HENDRYCH T., GÁŠKOVÁ D., GORONCY-BERMES P., SIGLER K.: Effect of biocides on S. cerevisiae: relationship between short-term membrane affliction and long-term cell killing. Folia Microbiol. 49, 718-725 (2004).
9. 2 arrest in fission yeast (Schizosaccharomyces pombe) through a pathway involving regulatory and catalytic subunits of PP2A and acting on both Wee1 and Cdc25. Virology 287, 359-370 (2001).
10. ELDER R.T., BENKO Z., ZHAO Y.: HIV-1 Vpr modulates cell cycle transition through an alternative cellular mechanism other than the classic mitotic checkpoints. Front.Biosci. 7, 349-357 (2002).
11. FAUCI A.S., PANTALEO G., STANLEY S., WEISSMAN D.: Immunopathogenic mechanisms of HIV infection. Ann.Med.Interne 124, 654 (1996).
12. FRANKHAUSER H., ZURLINDEN A., SCHWEINGRUBER A.M., EDENHARTER E., SCHWEINGRUBER M.E.: Schizosaccharomyces pombe thiamine pyrophosphokinase is encoded by gene tnr3 and is a regulator of thiamine metabolism, phosphate metabolism, mating, and growth. J.Biol.Chem. 47, 28457-28462 (1995).
13. GAZDAG Z., PÓCSI I., BELÁGYI J., EMRI T., BLASKÓ Á., TAKÁCS K., PESTI M.: Chromate tolerance caused by reduced hydroxyl radical production and decreased glutathione reductase activity in Schizosaccharomyces pombe. J.Basic Microbiol. 43, 96-103 (2003).
14. GILLE G., SIGLER K., HÖFER M.: Response of catalase activity and membrane fluidity of aerobically grown Schizosaccharomyces pombe and Saccharomyces cerevisiae to aeration and the presence of substrates. J.Gen.Appl.Microbiol. 139, 1627-1634 (1993).
15. GLISZCZYNSKA-SWIGLO A.: Antioxidant activity of water soluble vitamins in the TEAC (trolox equivalent antioxidant capacity) and the FRAP (ferric reducing antioxidant power) assays. Food Chem. 49, 718-725 (2005).
16. IORDANSKY S., ZHAO Y., DUBROVSKY L., IORDANSKAYA T., CHEN M., LLANG D., BUKRINKSKY M.: Heat shock protein 70 protects cells from cell cycle arrest and apoptosis induced by human immunodeficiency virus type 1 viral protein R. J.Virol. 78, 9697-9704 (2004).
17. JUNG I.L., KIM I.G.: Thiamine protects against paraquat-induced damage: scavenging activity of reactive oxygen species. Environ.Toxicol.Pharmacol. 15, 19-26 (2003).
18. KIM T.A., AVRAHAM H.K., KOH Y.H., JIANG S., PARK A.: HIV-1 Tat-mediated apoptosis in human brain microvascular endothelial cells. J.Immunol. 170, 2629-2637 (2003).
19. KURZWEILOVÁ H., SIGLER K.: Factors affecting the susceptibility of sensitive yeast cells to killer toxin K1. Folia Microbiol. 38, 524-526 (1993).
20. LACHGAR A., SOJIC N., ARBAULT S., BRUCE D., SARASIN A., AMATORE C., BIZZINI B., ZAGURY D., VUILLAUME M.: Amplification of the inflammatory cellular redox state by human immunodeficiency virus type-1 immunorepressive Tat and gp120 proteins. J. Virol. 73, 1447-1452 (1999).
21. MASUDA M., NAGAI Y., OSHIMA N., TANAKA K., MURAKAMI H., IGARASHI H., OKAYAMA H.: Genetic studies with the fission yeast Schizosaccharomyces pombe suggest involvement of Wee1, Ppa2, and Rad24 in induction of cell cycle arrest by human immunodeficiency virus type 1 Vpr. J. Virol. 74, 2636-2646 (2000).
22. MORENO S., KLAR A., NURSE P.: Molecular genetic analysis of fission yeast Schizosaccharomyces pombe. Meth.Enzymol. 194, 795-823 (1991).
23. MUTHUMANI R., HWANG D.S., DESAI B.M., ZHANG D., DAYES N., GREENT D.R., WEINER D.B.: HIV-1 Vpr induces apoptosis through caspase 9 in T cells and peripheral blood mononuclear cells. J.Biol.Chem. 277, 37820-37831 (2002).
24. NGUYEN A.N., SHIOZAKI K.: Heat shock-induced activation of stress MAP kinase is regulated by threonine and tyrosine-specific phosphatases. Genes & Develop. 13, 1653-1663 (1999).
25. PANTALEO G., GRAZIOSI C., DEMAREST J.F., BUTINI L., MONTRONI M., Fox C.H., ORENSTEIN J.M., KOTLER D.P., FAUCI A.S.: HIV-1 infection is active and progressive during the clinically latent period of infection. Nature 362, 355-358 (1993).
26. PERL A., BANKI K.: Genetic and metabolic control of the mitochondrial transmembrane potential and reactive oxygen intermediate production in HIV disease. Redox Signaling 2, 551-573 (2000).
27. PÓCSI I., PRADE R.A., PENNICKX M.J.: Glutathione, altruistic metabolite in fungi. Adv.Microb.Physiol. 49, 1-76 (2004).
28. POON B., CHEN I.S.Y.: Human immunodeficiency virus type 1 (HIV-1) Vpr enhances expression form unintegrated HIV-1 DNA. J. Virol. 77, 3962-3972 (2003).
29. + T cell populations specific for persistent DNA viruses. J.Exp.Med. 202, 1349-1361 (2005).
30. 2 levels in fission yeast Schizosaccharomyces pombe. Mol.Biol.Cell 13, 805-816 (2002).
31. RASPOR P., PLESNICAR S., GAZDAG Z., PESTI M., MIKLAVCIC M., LAH B., LOGAR-MARINŠEK R., POLJSAK B.: Prevention of intracellular oxidation in yeast: the role of vitamin E analogue, trolox (6-hydroxy-2,5,7,8- tetramethylchroman-2-carboxylic acid). Cell.Biol.Internat. 29, 57-63 (2005).
32. SHIOZAKI K., SHIOZAKI M., RUSSELL P.: Heat stress activates fission yeast Spc1/Sty1 MAPK by a MEKK-independent mechanism. Mol.Biol.Cell 9, 1339-1349 (1998).
33. SIES H.: Strategies of antioxidant defense. Eur.J.Biochem. 215, 213-219 (1993).
34. STARK L.A., HAY R.T.: Human immunodeficiency virus type 1 (HIV-1) viral protein R (Vpr) interacts with Lys-tRNA synthetase: implications for priming of HIV-1 reverse transcription. J. Virol. 72, 3037-3044 (1998).
35. TARICANI L., FEILOTTER H.E., WEAVER C., YOUNG P.G.: Expression of Hsp 16 in response to nucleotide depletion is regulated via the Spc1 MAPK pathway in Schizosaccharomyces pombe. Nucl.Acids Res. 29, 3030-3040 (2001).
36. TEKIN D., XI L., ZHAO T., TEJERO-TALDO M.I., ATLURI S., KUKEJA C.: Mitogen-activated protein kinases mediate heat shock-induced delayed protection in mouse heart. Am.J.Physiol.Heart Circ.Physiol. 281, 523-532 (2001).
37. TOONE W.M., JONES N.: Stress-activated signaling pathways in yeast. Genes Cells 3, 485-498 (1998).
38. TUNGATURTHI P.K., SAWAYA B.E., SINGH S.P., TOMKOWICZ B., AYYAVOO V., KHALILI K., COLLMAN R.G., AMINI S., SRINIVSASAN A.: Role of HIV-1 Vpr in AIDS pathogenesis: relevance and implications of intravirion, intracellular and free Vpr. Biomed.Pharmacother. 57, 20-24 (2003).
39. VALYI-NAGY T., DERMODY T.S.: Role of oxidative damage in the pathogenesis of viral infection of the nervous system. Histol.Histopathol. 20, 957-967 (2005).
40. WILKINSON M.G., MILLAR J.B.A.: SAPKs and transcription factors do the nucleoplasmic tango. Genes & Develop. 12, 1391-1397 (1998).
41. ZHU Y., GELBARD H.A., ROSHAL M., PURSELL S., JAMIESON B.D., PLANELLES V.: Comparison of cell cycle arrest, transactivation, and apoptosis induced by the simian immunodeficiency virus SIVagm and human immunodeficiency virus type 1 vpr genes. J.Virol. 75, 3791-3801 (2001).